Low Concentration ALA-PDT in Treatment of Skin Ulcer
Clinical Study of Low Concentration ALA-PDT in Treatment of Skin Ulcer
1 other identifier
interventional
28
1 country
1
Brief Summary
Skin ulcer is a common disease with complicated etiopathogenes, which makes it hard to be cured. It has been reported that photodynamic therapy (PDT) can be used to treat skin ulcers which were caused by different diseases. However, PDT is an expensive treatment and patients always experience obvious pain during or after the treatment, which hinders the application of PDT in skin ulcer. Our previous study found that PDT using a low concentration of 5-Aminolevulinic acid (ALA) could promote the healing of skin ulcer without obvious adverse reactions, which suggests us that low concentration ALA-PDT might be an efficient and cost effective treatment in skin ulcer. To further investigate the use of low concentration ALA-PDT in skin ulcer, we plan to recruit patients with skin ulcers caused by different diseases, and divide these patients into different groups according to their causes of disease, and then treat them using low concentration ALA-PDT to observe the healing process of skin ulcer. This study could further optimize and promote the use of low concentration ALA-PDT in skin ulcer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 26, 2020
CompletedFirst Posted
Study publicly available on registry
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedDecember 30, 2020
December 1, 2020
2 years
December 23, 2020
December 29, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
ulcer area size
The ulcer area size was measured
Change from Baseline ulcer area size at 24 hours after the last treatment.
Secondary Outcomes (1)
total bacterial load
Change from Baseline total bacterial load at 24 hours after the last treatment.
Study Arms (2)
ALA-PDT
EXPERIMENTALred light
OTHERInterventions
Eligibility Criteria
You may qualify if:
- chronic skin wounds that involved the dermis and did not heal in three months or did not exhibit a tendency toward healing
You may not qualify if:
- allergies to photosensitizers and their solvents, serious medical illnesses, such as severe heart disease, severe liver or kidney dysfunction, systemic infection or any concomitant infection that would require treatment with an additional antimicrobial agent, the use of topical or systemic antibiotics within one month prior to treatment. Pregnant or lactating women were also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610031, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
December 23, 2020
First Posted
December 30, 2020
Study Start
January 1, 2019
Primary Completion
December 26, 2020
Study Completion
December 30, 2020
Last Updated
December 30, 2020
Record last verified: 2020-12